CHICAGO, IL and Oxford, UK - March 6, 2007
Oxford Gene Technology (OGT) and Integrated Genomics (IG) today announced the signing of a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray. The collaboration gives OGT access to IG’s proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimized 60 mer oligonucleotide microarray using the ink jet in-situ synthesis (IJISS) platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.
Mr James Clough, Commercial Director at OGT said: "We are delighted to be working with Integrated Genomics. The combination of OGT’s oligonucleotide array expertise combined with Integrated Genomics sequence and detailed Pichia genome annotations will be a powerful molecular research tool for the Pichia community and add strength to our growing portfolio."
Dr Theresa Walunas, Vice President of Integrated Genomics added: "OGT’s IJISS technology provides an important new capability to the Pichia research community. Microarrays will allow researchers to understand how Pichia’s gene expression changes in response to genetic modifications."
About Integrated Genomics, Inc.
Integrated Genomics provides bioinformatics products and services for the life science industry, with a recent focus on the use of in silico strategies for comparative genomics. The company’s expertise in industrial and medicinal microbial genomics includes genome sequencing, genome analysis and custom bioinformatics. IG has developed ERGO™, the most advanced and comprehensive bioinformatics suite for microbial genomics on the market. ERGO™ contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions and representing the chemical reaction networks of metabolic pathways.
Vinayak Kapatral, Ph.D.
Vice President, Business Development
(312) 491-0846 ext.326
Oxford Gene Technology
+44 1865 856352